Nihal KARAYER, Serkan ERGÖZEN, Volkan YILMAZ, Gönen MENGİ

Romatoid Artrit ve Orak Hücreli Anemi Birlikteliği; Olgu Sunumu

Romatoid artrit (RA) primer olarak sinovyal eklemleri etkileyen, kronik, sistemik, otoimmün bir hastalıktır. Orak hücreli anemi, hemoglobin yapısında bozuklukla ilişkili vazo-okluziv ataklarla seyreden kalıtsal, kronik bir hastalıktır. Romatoid artrit ve orak hücreli anemi birlikteliği literatürde nadir olarak bildirilmektedir. Bu vaka sunumunda 26 yaşında orak hücreli anemi tanısı olan bilateral el artrit bulgularıyla polikliniğimize başvuran kadın hastanın literatür eşliğinde tanı ve tedavi planı sunulacaktır.

Anahtar Kelimeler:

Romatoid artrit, Orak hücreli anemi, Avasküler nekroz

Coexistence of Rheumatoid Arthritis and Sickle Cell Anemia; Case Report

Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune disease that primarily affects the synovial joints. Sickle cell anemia is a chronic inherited disease with vaso-occlusive attacks associated with hemoglobin structure defect. The coexistence of rheumatoid arthritis and sickle cell anemia is rarely reported in the literature. In this case report, the diagnosis and treatment plan of a 26-year-old female patient who was diagnosed with sickle cell anemia and applied to our outpatient clinic with bilateral hand arthritis findings will be presented in the light of the literature.

Keywords:

Rheumatoid arthritis, Sickle cell anemia, Avascular necrosis,

PDF

___

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094-108.
2. Gravitz L, Pincock S. Sickle-cell disease. Nature. 2014;515(7526):S1.
3. Leung MHK, Hughes M, Lane J, et al. Severe disability in a patient with rheumatoid arthritis and sickle cell anemia. J Clin Rheumatol. 2015;21(8):458-9.
4. Nistala K, Murray KJ. Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy. J Rheumatol. 2001;28(9):2125-8.
5. McFarlane IM, Ozeri DJ, Saperstein Y, et al. Rheumatoid arthritis in sickle-cell population: pathophysiologic insights, clinical evaluation and management. Rheumatology (Sunnyvale). 2017;7(3):225.